about
Narrative review: the systemic capillary leak syndromePrimary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapyA primer of amyloid nomenclatureWaldenström macroglobulinemia: my way.Pathogenesis of renal failure in multiple myeloma: any role of contrast media?Vasculitis with renal involvement in essential mixed cryoglobulinemia: Case report and mini-reviewSporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 casesThe clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.Primary amyloidosis of the breast presenting as a solitary nodule: case report and review of the literature.Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis.Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy.A strategy for synthesis of pathogenic human immunoglobulin free light chains in E. coli.Site-directed mutagenesis reveals regions implicated in the stability and fiber formation of human λ3r light chainsDifferential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycansAmyloidosis: pathogenesis and new therapeutic options.Thymic stromal lymphopoietin (TSLP)-induced polyclonal B-cell activation and autoimmunity are mediated by CD4+ T cells and IL-4.Cancer-testis antigen expression and immunogenicity in AL amyloidosis.The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic.Updates in cardiac amyloidosis: a review.Management of paraproteinaemia.Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis.A Patient with Abnormal Kidney Function and a Monoclonal Light Chain in the Urine.Perspectives in treatment of AL amyloidosis.Amyloidosis: 2008 BMT Tandem Meetings (February 13-17, San Diego).Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis.Clinical Relevance of Trace Bands on Serum Electrophoresis in Patients Without a History of GammopathySchnitzler syndrome: an under-diagnosed clinical entity.Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.Long-term reversibility of renal dysfunction associated to light chain deposition disease with bortezomib and dexamethasone and high dose therapy and autologous stem cell transplantation.Kidney disease associated with plasma cell dyscrasiasLight chain amyloidosis: a case presentation and review.Type I cryoglobulinemia in multiple myeloma, a rare entity: analysis of clinical and biological characteristics of seven cases and review of the literature.A concise review of amyloidosis in animals.Light chain amyloidosis 2012: a new era.Systemic amyloidoses.Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.Current treatments for renal failure due to multiple myeloma.Kidney disease and multiple myeloma.Pathophysiology and treatment of systemic amyloidosis.
P2860
Q24603534-BE80F4F5-18E1-465C-9C3B-3EFEBACA3EFFQ24646477-435F037C-4A40-4264-A945-3EFD5755A2E0Q28241008-09A1DA50-C3B7-495F-8953-1E843256AD99Q33402669-0FF5D084-7B0C-4431-BFF3-4489D4CC0C1CQ33616884-0627BD29-585C-426D-B4F9-CF1455DCC513Q33621208-4696E6FD-47BD-4A76-8AD7-3CD077F7552FQ33660088-09880CB6-4F6E-48C6-96F8-29B029F95DF8Q33695919-08BA8571-842B-40DF-815F-C19F3C09A463Q33737558-005A32F9-42F5-4414-8D3A-344ECE5BCF23Q34091229-9BF44161-5D4F-4B1A-9792-DD07704BCA80Q34525834-86668500-554B-4D12-913F-C1DE0F4FFE65Q34788837-E9F8B284-2CD6-4E29-ADFF-98D68312B88DQ35006134-160ACF95-E3FC-4314-A68D-76E05D09B447Q35048946-7E5E8899-4138-4B6C-B1E3-84A0F7053D64Q35103966-6A092E70-6766-43E8-AA93-A303CC5F5079Q35111771-F9A1AE1C-D85C-4106-8BFB-B2722555F46AQ35772600-D19A2EFB-2D0D-4B23-832C-E27436F40B77Q36289604-4FA13337-2083-435B-8582-216E00F3E12CQ36356006-0921A7B2-4E37-4B26-BB68-DE162FC53BBEQ36366356-14B5346A-56C8-4781-9FB4-9F8AAD60C670Q36778432-B3D098B4-E40C-4BBB-92F4-F205AF4B26DFQ36779759-6544E184-591D-4288-8059-3AEC3D8E8A0EQ36965127-E29911BB-972B-46C1-BFB9-8FAD0DF0822CQ37045885-3CBC236E-D78E-4348-A7F9-63316D2B3B14Q37045900-C4F322D7-F746-4809-A8E0-FBDF301606A4Q37094919-EFB906FF-B247-4968-96D6-59429F316DEFQ37155482-5493D44F-0A06-4924-B5B9-69291B8F5541Q37212707-5E4B1E6E-E474-4711-B4B0-E3D98A643EEAQ37329516-C90CA0A2-0B6F-41F9-BF44-DCF0C652E4EBQ37694425-7DE28409-CD06-4108-9E58-876070D582D8Q37750106-F5CA058F-75AF-4B89-B4FA-FAB815F899AFQ37829345-4BE6D15B-B498-42B3-B92E-9C9F51E94F5BQ37990030-2C85E39D-91CA-4421-B367-8CA1DB51568DQ38009325-2CD5ADC7-15E2-4F6F-93DA-DB9832975CA7Q38072108-F403134B-5D5C-403F-8658-630417984E6AQ38085664-0D644441-B891-4FBD-AF24-2C512FB0563EQ38100588-999BDE3D-D43C-4CDC-BB53-21CEA4A2556FQ38109235-0B3C2CB5-4AAF-4F64-B647-C5465EB6A092Q38122674-913CC63E-FD98-4B84-A0BE-001359F49291Q38131710-0F6D0447-BC5E-4EFA-A12E-1A7D70B14EBA
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Dangerous small B-cell clones.
@ast
Dangerous small B-cell clones.
@en
type
label
Dangerous small B-cell clones.
@ast
Dangerous small B-cell clones.
@en
prefLabel
Dangerous small B-cell clones.
@ast
Dangerous small B-cell clones.
@en
P1433
P1476
Dangerous small B-cell clones
@en
P2093
Marvin J Stone
P304
P356
10.1182/BLOOD-2006-03-001164
P407
P577
2006-06-22T00:00:00Z